Effects of curcuminoids on inflammatory status in patients with non-alcoholic fatty liver disease: A randomized controlled trial

M Saberi-Karimian, M Keshvari… - … therapies in medicine, 2020 - Elsevier
Background Nonalcoholic fatty liver diseases (NAFLD) is a highly prevalent disease that is
closely associated with several cardiometabolic complications. The potential anti-
inflammatory role of curcuminoids that have already been reported to reduce hepatic
steatosis, in patients with NAFLD was explored in this study. Methods This double-blind,
randomized placebo-controlled trial was conducted for a period of 8 weeks in patients with
NAFLD. Subjects (n= 55) were randomly allocated to receive either curcuminoids or …
以上显示的是最相近的搜索结果。 查看全部搜索结果